ISRCTN23628366已完成未知
Phase III Trial comparing CHOP to PmitCEBO in Good Risk patients with Histologically Aggressive Non-Hodgkin's Lymphoma
British National Lymphoma Investigation (BNLI) (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
2009 results in http://www.ncbi.nlm.nih.gov/pubmed/19450285
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Previously untreated non-Hodgkin's Lymphoma of the following types: follicular large cell lymphoma, diffuse mixed cell lymphoma diffuse large cell lymphoma diffuse immunoblastic lymphoma 0r Revised European/American Lymphoma (REAL) classification: diffuse large B peripheral T cell lymphoma
- •2. Bulky stage IA and stages IB-IV (Ann Arbour staging system)
- •3. Age 18-59 years
- •4. Measurable or evaluable disease
- •5. Good prognosis, defined as the presence of no more than one of the following adverse features: Stage III/IV Lactic dehydrogenase (LDH) >upper limit of normal Performance status 2-4 (Eastern Cooperative Oncology Group [ECOG]-World Health Organisation [WHO]) Adequate bone marrow function, indicated by Haemoglobin =10 g/dL Neutrophils =2 x 10^9/L Platelets =100 x 10^9/L
- •6. Written informed consent
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
已完成
不适用
Trial of CHOP versus CIOP in Good Risk Stage II-IV Patients with Histologically Aggressive Non-Hodgkin's Lymphomaymphoma (non-Hodgkin's)Lymphoma (non-Hodgkin's)CancerISRCTN26863825British National Lymphoma Investigation (BNLI) (UK)211
已完成
不适用
A randomised prospective trial of CHOP versus MCOP in elderly patients with intermediate and high grade non-Hodgkins lymphomaymphoma (non-Hodgkin's)Lymphoma (non-Hodgkin's)CancerISRCTN39268693Cancer Research UK (CRUK) (UK)
招募中
1 期
Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCLDiffuse Large B-Cell LymphomaNCT06760039Sun Yat-sen University112
已完成
3 期
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCLLymphomaNCT00854568Fudan University398
已完成
3 期
CHOP versus PMItCEBO with/without G-CSF in patients aged sixty years plus with non-hodgkin's lymphomaon-Hodgkin's lymphomaNon-Hodgkin's lymphomaCancerISRCTN98741793ymphoma Research Trust (UK)880